A Research Study to Test the Effectiveness of MK0217 in Patients With Paget's Bone Disease (0217-206)(COMPLETED)
Condition: Paget's Disease of BoneIntervention: Drug: alendronateSponsor: Merck Sharp & Dohme Corp.Completed - verified February 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials